BDBM221152 US9303012, 78
SMILES: CC1(C)C[C@H](N(C1)C(=O)c1ccc(N2CC(F)(F)C2)c(OCC2CC2)n1)C(N)=O
InChI Key: InChIKey=GVEPGDZAQOFWPS-HNNXBMFYSA-N
Data: 2 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cannabinoid receptor 1 (Homo sapiens (Human)) | BDBM221152 (US9303012, 78) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | 37 |
HOFFMAN-LA ROCHE INC. US Patent | Assay Description CHO cells expressing human CB1 or CB2 receptors are seeded 17-24 hours prior to the experiment 50.000 cells per well in a black 96 well plate with fl... | US Patent US9303012 (2016) BindingDB Entry DOI: 10.7270/Q2FF3R7H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM221152 (US9303012, 78) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.20 | n/a | n/a | n/a | 37 |
HOFFMAN-LA ROCHE INC. US Patent | Assay Description CHO cells expressing human CB1 or CB2 receptors are seeded 17-24 hours prior to the experiment 50.000 cells per well in a black 96 well plate with fl... | US Patent US9303012 (2016) BindingDB Entry DOI: 10.7270/Q2FF3R7H | |||||||||||
More data for this Ligand-Target Pair |